Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Edwards Lifesciences

IBD Stock Of The Day Edwards Lifesciences Is Eyeing $15 Billion — And A Buy Point

Edwards Lifesciences is the IBD Stock Of The Day as the easing Covid pandemic allows for bullish growth in TAVR procedures in the U.S.

Investors Business Daily

Dow Jones Climbs As Treasury Yields Continue To Rise; Twitter Reverses After Poison Pill Plan

The Dow Jones Industrial Average rose Monday, as Treasury yields extended gains. Twitter stock turned lower after adopting a poison pill plan.

Investors Business Daily

Pfizer Stock, Raytheon Lead 5 Stocks Near Buy Points

Pfizer and Raytheon are among 5 stocks near buy points that offer protection from geopolitics and aggressive rate-hikes.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Fall As Market Rally Weakens; Tesla Shanghai Tries To Reopen, Twitter Pops

The market rally is ailing, but not all areas. Tesla Shanghai is working to reopen with earnings due. Twitter stock popped.

Investors Business Daily

Dow Jones Rallies As Twitter Jumps On Elon Musk Buyout Offer

The Dow Jones Industrial Average rose, as Twitter stock jumped after Elon Musk offered to buy the company.

Investors Business Daily

Expert Ratings for Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Climbs As Earnings Season Kicks Off; JPMorgan Slides On Earnings Miss

The Dow Jones Industrial Average rose Wednesday, as earnings season kicks off. JPMorgan stock slid after missing earnings estimates.

Investors Business Daily

Dow Jones Rallies After Key Inflation Report As White House Warns Of 'Extraordinarily Elevated' Inflation

The Dow Jones Industrial Average rallied Tuesday after a key inflation report following Monday's stock market sell-off.

Investors Business Daily

Dow Jones Futures: What To Do After Stock Market Sell-Off; White House Warns Of 'Extraordinarily Elevated' Inflation

Dow Jones futures were higher early. Here's what to do after Monday's stock market sell-off ahead of today's key inflation report.

Investors Business Daily

Heart Valve Maker Eyes Breakout After Getting An FDA Approval

As heart valve maker Edwards Lifesciences wins a new FDA approval, the stock looks to pump out a fresh breakout.

Investors Business Daily

Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors

Raytheon Technologies and Shell are just below buy points, headlining five stocks from strong sectors.

Investors Business Daily

FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery

The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral position.

Benzinga

What 9 Analyst Ratings Have To Say About Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyst Ratings For Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

This Foreboding Sign Looms Over Edwards Lifesciences's Chart

If history is any guide, there may be trouble ahead for shares of Edwards Lifesciences (NYSE:EW). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Where Edwards Lifesciences Stands With Analysts

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook

Heart device company Edwards Lifesciences Corp (NYSE: EW) posted

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Edwards Lifesciences: Q4 Earnings Insights

Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Investors Business Daily

Omicron Weighs On Edwards Lifesciences In The Fourth Quarter — So, What's Next?

The omicron variant weighed on Edwards in late 2021, leading to a fourth-quarter miss and pushing EW stock into a dive Thursday.

Benzinga

Preview: Edwards Lifesciences's Earnings

Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Edwards Lifesciences will likely report an Earnings Per Share (EPS) of $0.55.

1 2 3

People

Elon Musk

23,519 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.